Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...
Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.
New types of T cells seem to pop up in the scientific literature with increasing frequency. Just this June, for instance, University of Melbourne immunologist Angela Pizzolla and her colleagues ...
Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...
Researchers have developed a new method for growing T cells in the lab, allowing them to survive longer and fight cancer more effectively. This advancement, detailed in Cell Metabolism, could ...
Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...